HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 6.5% up today after FDA guidance clarified IND next steps
HCW Biologics is trading at $1.63, up +6.54%, after FDA Type B meeting guidance clarified next steps for its planned first-in-human solid-tumor study of...
🔴 HCW Biologics is trading 5% down in pre-market
HCW Biologics is trading at $1.48, down 5.34% in pre-market, with no clear company-specific announcement dated October 8 explaining the decline. - Recent...
🔴 HCW Biologics is trading 7.1% down
HCW Biologics is trading 7.1% down at $1.56 on October 5, 2026, with no confirmed company announcement or clear catalyst identified. - The price continued...
🔴 HCW Biologics is trading 7.7% down in pre-market with no confirmed catalyst
HCW Biologics is trading at $1.55, down 7.7% in pre-market on October 5, 2026; the cause remains unconfirmed. - Shares closed at $1.68 October 2, after falling...
🟢 HCW Biologics is trading 7% up in pre-market with no clear catalyst identified
HCW Biologics is trading at $1.83, up 7.02%, in pre-market on October 1, with no clear company-specific catalyst identified. - Its latest news-release page...
🔴 HCW Biologics is trading 5% down in pre-market with no clear catalyst identified
HCW Biologics is trading at $1.73, down 5.04%, with no clear catalyst identified for the September 29 pre-market decline. - No new company-specific...
🔴 HCW Biologics is trading 5.5% down in after-hours trading amid broader risk-off sentiment
HCW Biologics is trading 5.5% lower at $1.72 after-hours, with broader market weakness as possible context; no company-specific announcement explaining the...
🔴 HCW Biologics is trading 11.36% down today as oil and Treasury yields revive inflation fears
HCW Biologics is trading 11.36% down at $1.71, with broader macro risk-off sentiment the clearest available context for the decline. - Rising oil prices and...
🔴 HCW Biologics is trading 6.7% down as oil and bond yields revived inflation concerns
HCW Biologics is trading at $1.80, down 6.74%, amid broader risk-off pressure. - Reuters reported September 28 that shares were mostly lower as rising oil...
🔴 HCW Biologics is trading 5.18% down in pre-market after $1.5 million private placement
HCW Biologics is trading at $1.83, down 5.18%, in pre-market after its September 24 announcement of a $1.5 million private placement with an existing...
🔴 HCW Biologics is trading 5% down in after-hours trading after $1.5 million dilutive private placement
HCW Biologics is trading at $1.83, down 5.18%, in after-hours trading, as dilution concerns follow its private-placement announcement. - On September 25, 2026,...
🔴 HCW Biologics is trading 5.41% down today as $1.5 million placement raises dilution concerns
HCW Biologics is trading 5.41% lower at $1.88 after investors reacted to its September 24, 2026 announcement of a $1.5 million private placement. - The...
🔴 HCW Biologics is trading 8.88% down in pre-market after a $1.5 million private placement
HCW Biologics is trading at $1.81, down 8.88%, after announcing a $1.5 million private placement on September 24, 2026. - The financing includes 903,614...
🔴 HCW Biologics is trading 6.5% down in after-hours trading after a $1.5 million private placement announcement
HCW Biologics is trading 6.5% down at $1.86 after announcing a $1.5 million private placement, which may be prompting after-hours reassessment following its...
HCW Biologics Surges 43% on a Tiny $1.5 Million Deal — Is This a Lifeline or a Last Resort?
Shares of HCW Biologics rocketed 43.4% to $2.38 on September 24 after the micro-cap biotech priced a $1.5 million private placement with an existing...
🟢 HCW Biologics is trading 43.37% up today after pricing a $1.5 million private placement
HCW Biologics is trading 43.37% up at $2.38 after announcing pricing for a $1.5 million private placement with an existing stockholder. - The financing...
🟢 HCW Biologics is trading 6.33% up today amid a $1.5 million private placement announcement
HCW Biologics is trading 6.33% higher at $1.76 amid its announcement of a $1.5 million private placement; the announcement did not explicitly attribute the...
🟢 HCW Biologics is trading 5.42% up in pre-market
HCW Biologics is trading 5.42% higher at $1.75 in pre-market, with no new company-specific announcement identified to explain the rebound. - Shares closed at...
🟢 HCW Biologics is trading 5.42% up in after-hours trading
HCW Biologics is trading at $1.75, up 5.42% in after-hours trading, with no clear company-specific catalyst identified for the rebound. - Shares closed the...
🔴 HCW Biologics is trading 10.5% down today amid higher oil prices and Treasury yields
HCW Biologics is trading 10.5% lower at $1.62 amid a broader market retreat linked to higher oil prices, Treasury yields and cautious risk sentiment. - No...